GL1X · GenesisL1 explorer

Research workbench

Mouse cereblon thalidomide binding domain, selenomethionine derivative

Analyse Mouse cereblon thalidomide binding domain, selenomethionine derivative in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3WX1
Type
protein
Length
207 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protein cereblon
UniProt
Q8C7D2
Ligands
ZN, SO4
Pockets
1 · best druggability 0.32

Structure

x-ray diffraction · 2 distinct chains · 9% helix, 43% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProtein cereblonprotein10811% helix, 42% strandQ8C7D2
BProtein cereblonprotein996% helix, 45% strandQ8C7D2

Ligands and binding sites

  • ZN · Zinc ion · metal · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · 4 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1690.320.7517empty

Interfaces

1 interface between chains.

  • A–B · 382 Ų buried · 6 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 modified (engineered).

Compared structures

  • 3WX1 · Mouse Cereblon thalidomide binding domain, selenomethionine derivative · the same entry in another collection · chain A against A, TM-score 1.00
  • Q8C7D2 · AlphaFold monomer V2.0 prediction for protein cereblon (Q8C7D2) · a predicted model of the same protein · chain B against A, TM-score 0.92

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.